Twitter is a real-time information network that connects you to the latest stories, ideas, opinions and breaking news about what you find interesting. Simply select the accounts you find most compelling and follow the conversations. At the heart of Twitter are small bursts of information called Tweets…
Each Tweet is 140 characters long maximum, but don’t let the small size fool you—you can discover a lot in a little space.
You can see photos, videos and conversations directly in Tweets…
Get Value from Twitter without sending Tweets
You don’t have to build a web page to surf the web, and you don’t have to tweet to enjoy Twitter. Whether you tweet a lot or never, you have access to the voices and information surrounding all your interests. You can contribute, or just listen in and retrieve your breaking news.
Get FACS “breaking” News via Twitter
Please find a list of Twitter accounts providing updates about the Fetal Anti Convulsant Syndromes related issues
At twenty-five, Judith was diagnosed with DES-related cervical cancer. After a radical hysterectomy she went to her family’s home to heal and picked up her camera. The resulting video-diary is a fascinating exploration of how science, marketing and corporate power can affect our deepest relationships.
Shot over five years, A Healthy Baby Girl tells a story of survival, mother-daughter love, family renewal, and community activism. Intimate, humorous, and searing, it is an invaluable resource for anyone interested in the relationship between women’s health, public policy, medical ethics and corporate responsibility. Watch the video trailer.
According to a recent cohort study, children who were conceived with in vitro fertilization IVF have no increase in the overall risk of #cancer – developed before 15 years of age – as those conceived naturally
Dr Alastair Sutcliffe – specialist in both general and adolescent paediatrics – and his team tracked more than 100,000 children conceived by IVF from 1992 to 2008 and compared the cancer rates in those children with those observed across the whole population of children in UK.
According to the cohort study, children who were conceived with in vitro fertilization have no increase in the overall risk of cancer – developed before 15 years of age – as those conceived naturally.
We linked data on all children born in Britain between 1992 and 2008 after assisted conception without donor involvement with data from the United Kingdom National Registry of Childhood Tumours to determine the number of children in whom cancer developed before 15 years of age. Cohort cancer rates were compared with population-based rates in Britain over the same period, with stratification for potential mediating and moderating factors, including sex, age at diagnosis, birth weight, singleton versus multiple birth, parity, parental age, type of assisted conception, and cause of parental infertility.
Full Text of Methods…
The cohort consisted of 106,013 children born after assisted conception (700,705 person-years of observation). The average duration of follow-up was 6.6 years. Overall, 108 cancers were identified, as compared with 109.7 expected cancers (standardized incidence ratio, 0.98; 95% confidence interval [CI], 0.81 to 1.19; P=0.87). Assisted conception was not associated with an increased risk of leukemia, neuroblastoma, retinoblastoma, central nervous system tumors, or renal or germ-cell tumors. It was associated with an increased risk of hepatoblastoma (standardized incidence ratio, 3.64; 95% CI, 1.34 to 7.93; P=0.02; absolute excess risk, 6.21 cases per 1 million person-years) and rhabdomyosarcoma (standardized incidence ratio, 2.62; 95% CI, 1.26 to 4.82; P=0.02; absolute excess risk, 8.82 cases per 1 million person-years), with hepatoblastoma developing in 6 children and rhabdomyosarcoma in 10 children. The excess risk of hepatoblastoma was associated with low birth weight.
Full Text of Results…
There was no increase in the overall risk of cancer among British children born after assisted conception during the 17-year study period. Increased risks of hepatoblastoma and rhabdomyosarcoma were detected, but the absolute risks were small. (Funded by Cancer Research UK and others.)
Leading cancer research centers team up to launch biotech startup focused on cancer immunotherapy
The Fred Hutchinson Cancer Research Center (“The mission of Fred Hutchinson Cancer Research Center is the elimination of cancer and related diseases as causes of human suffering and death.”) and Memorial Sloan-Kettering Cancer Center (“At Memorial Sloan-Kettering Cancer Center (MSK), we’re committed to exceptional patient care, research, and education.”), along with pediatric partner Seattle Children’s Research Institute (“Proud to be one of the top children’s hospitals & pediatric research institutes in the US. Supported by a generous community, like you. Hope. Care. Cure.”), have joined forces to launch Juno Therapeutics Inc., a new biotechnology company focused on bringing forward novel immunotherapies for cancer.
Significant breakthrough could tackle over-diagnosis and over-treatment of breast cancer
When we talk about breast cancer this usually means tumours that grow into the surrounding breast tissue, called invasive breast cancer.
However, sometimes cancerous changes develop within the lobules or ducts of the breast and do not break out into the surrounding tissue.
Ductal Carcinoma In Situ (DCIS) refers to non-invasive cancerous changes that are contained within the ducts. Researchers believe they have identified a molecule – called αvβ6 (alpha v beta 6) – that could be key to preventing over-treatment of breast cancer by revealing which cases of DCIS are most likely to develop into early invasive breast cancer.
Around 4,800 cases of DCIS are diagnosed each year in the UK with early signs of breast cancer but until now doctors have been unable to distinguish between the cases which will become dangerous, and those which do not need treatment.
Scientists say they have made a huge step forward in developing a simple test, which could free half such women from undergoing needless surgery and gruelling sessions of radiotherapy and hormone therapy.
Thalidomide victims to share massive settlement after successful class action
Great news: more than one hundred Australians and New Zealanders living with severe physical deformities because of thalidomide will share in an $89 million settlement after a class action ended in Melbourne.
The British multinational owner of the company that distributed the drug in Australia, agreed to the settlement.
The Independent Investigation Of Mammography The Medical Profession Doesn’t Want You To Know About
“The Mammogram Myth”, the result of an independent investigation by Rolf Hefti, dismantles – error by error- the official medical claims about the value of mammograms, such as that they are very safe, and greatly reduce breast cancer mortality.
This (e)book describes the “inconvenient” research data that has been dismissed and disregarded by the traditional medical profession (such as the true risks of medical radiation). It is the largely ignored but factual scientific evidence against the use of mammograms.
The official medical claims made by orthodox medicine about mammography appear convincing to both doctors and the public at large. Yet, the theory and claims promoting the screening practice are based on flawed research data and sustained by omitting and discounting relevant dissenting scientific evidence. Mammography is a case of “dogma over science” says the author of ” The Mammogram Myth”.
In the foreword to “The Mammogram Myth”, Ray Peat, PhD stated, “Women concerned about the risk of breast cancer will obviously want to read it, and if doctors who regularly advise their patients to have mammograms decide to read it looking for justification of their policy, they will encounter information about cancer in general and health in general that should change their life.”